Page 3 - Emergent Biosolution News Today

The healthcare stock will soon be booted from an index tracked by several ETFs.

As July draws to a close, it's time to take a look at the biotech stocks awaiting FDA decision in August..

(Reuters) -Emergent BioSolutions said on Thursday the U.S. Food and Drug Administration has approved its anthrax vaccine for use in adults aged 18 through ...

The U.S. Food and Drug Administration on Monday approved Opiant Pharmaceuticals Inc's nasal spray for reversing opioid-related overdoses, expanding treatment options in the country's fight against a crisis that has killed hundreds of thousands.

The Food and Drug Administration approved a nasal-spray medication touted as another option to reverse overdoses caused by synthetic opioids, including fentanyl, the drug killing tens of thousands of Americans each year.

The music festival season has kicked off, and drug overdoses are expected to rise alongside it.

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff

The spray version of naloxone can now be purchased without a prescription in the US

Manufacturers of medical devices must now show regulators when they apply to the FDA for authorization that they can monitor and address cybersecurity threats once products are on the market.

Naloxone reverses drug overdose caused by opioid, and making it accessible is a lifesaving measure